no more tirzepatide The FDA has declared an end to the two-year shortage of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes drug Mounjaro — meaning that far people could Tirzepatide vs. Semaglutide for Weight

| When coupled with wraparound lifestyle support, 63% of Omada members maintained or continued to lose weight 12 months after discontinuing GLP-1s.

Blood pressure: Systolic BP reduction of ~17 mmHg, clinically relevant in patients with cardiometabolic risk

People are losing more weight than ever, it seems.

Tirzepatide activates dual GLP-1 and GIP receptors to reduce hunger and increase fat breakdown, with clinical evidence showing preferential loss of dangerous visceral belly fat over subcutaneous reserves

GLP-1 receptor agonists can support weight loss across different target amounts, including modest 10-pound goals

Compared with semaglutide QW, the discontinuation rate was significantly higher for dulaglutide (hazard ratio [HR] 1.22